Study to Evaluate the Pharmacokinetics, Safety, and QTc Effect of AG-348 in Healthy Subjects of Japanese Origin and Non-Asian Origin
Clinical trial NCT03250598 · COMPLETED
Trial details
- NCT number
- NCT03250598
- Sponsor
- Agios Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-09
- Primary completion
- 2017-10-02
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.